The landscape of cellular biology has long been defined by a fundamental trade-off: the desire to see the internal "machinery"…
Read More
Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion
Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…
Read More
Rice University Researchers Develop First Comprehensive Label-Free Molecular Atlas of the Alzheimer’s Brain
In a significant leap forward for neurodegenerative research, a multidisciplinary team at Rice University has successfully generated the first comprehensive,…
Read More
